Stockreport

Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference

Compass Therapeutics, Inc.  (CMPX) 
PDF BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietar [Read more]